Advanced Enzyme Tech Share Price
Advanced Enzyme Tech Share Price Today
As of 5 Jul 2026, Advanced Enzyme Tech share price is ₹317.60. The stock opened at ₹314.00, compared to its previous close of ₹313.45. During today's trading session, Advanced Enzyme Tech share price moved in the range of ₹314.00 to ₹327.95, with an average price of ₹320.98 for the day. Looking at its last 52-week, the stock has touched a low of ₹251.95 and a high of ₹419.00. On the performance front, Advanced Enzyme Tech share price has increased by 5.11% over the last six months and is down 6.02% on a year-on-year basis.
Advanced Enzyme Tech Returns Calculator
Advanced Enzyme Tech Shareholder Returns
Advanced Enzyme Tech Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
Advanced Enzyme Tech Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹636.91 | ₹623.87 | ₹540.64 | ₹529.38 |
| Other Income | ₹33.04 | ₹36.66 | ₹25.46 | ₹6.42 |
| Total Revenue | ₹669.95 | ₹660.53 | ₹566.09 | ₹535.80 |
| Total Expenses | ₹482.59 | ₹457.58 | ₹421.64 | ₹364.75 |
| Profit Before Tax | ₹187.36 | ₹187.82 | ₹140.39 | ₹171.06 |
| Tax | ₹53.39 | ₹50.87 | ₹36.52 | ₹47.26 |
| Profit After Tax | ₹133.97 | ₹136.95 | ₹103.87 | ₹123.80 |
| EPS - Basic | ₹11.72 | ₹11.92 | ₹9.45 | ₹10.70 |
| EPS - Diluted | ₹11.71 | ₹11.92 | ₹9.45 | ₹10.68 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹187.36 | ₹187.82 | ₹140.39 | ₹171.06 |
| Income before WC changes | ₹214.40 | ₹216.86 | ₹177.34 | ₹204.22 |
| Change in Assets | -₹12.20 | -₹26.21 | -₹7.83 | -₹26.83 |
| Change in Liabilities | -₹0.03 | -₹0.05 | ₹7.49 | -₹0.57 |
| Change in WC | -₹12.23 | -₹26.25 | -₹0.34 | -₹27.40 |
| Cash flow from Operations | ₹142.50 | ₹141.37 | ₹140.36 | ₹122.29 |
| Cash flow from Investing | -₹89.10 | -₹64.65 | -₹298.18 | -₹3.79 |
| Cash flow from Financing | -₹72.54 | -₹59.24 | -₹25.80 | -₹48.50 |
| Total Cash Flow | -₹19.15 | ₹17.48 | -₹183.62 | ₹70.00 |
| Cash (Start of the year) | ₹113.75 | ₹96.42 | ₹267.36 | ₹191.92 |
| Cash (End of the year) | ₹94.23 | ₹113.75 | ₹96.42 | ₹267.36 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹741.48 | ₹725.72 | ₹699.74 | ₹663.17 |
| Current Assets | ₹879.87 | ₹809.74 | ₹722.11 | ₹604.44 |
| Total Assets | ₹1,621.35 | ₹1,535.46 | ₹1,421.85 | ₹1,267.61 |
| Current Liabilities | ₹96.76 | ₹106.36 | ₹77.57 | ₹60.42 |
| Net Current Asset | ₹783.11 | ₹703.39 | ₹644.54 | ₹544.02 |
| Non-Current Liabilities | ₹55.92 | ₹58.03 | ₹60.11 | ₹66.80 |
| Equity Capital | ₹1,468.67 | ₹1,371.08 | ₹1,284.17 | ₹1,140.39 |
| Total Equity & Liabilities | ₹1,621.35 | ₹1,535.46 | ₹1,421.85 | ₹1,267.61 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹351.41 | ₹365.47 | ₹311.53 | ₹272.80 |
| Other Income | ₹61.49 | ₹58.81 | ₹9.81 | ₹9.08 |
| Total Revenue | ₹412.90 | ₹424.28 | ₹321.34 | ₹281.88 |
| Total Expenses | ₹292.37 | ₹271.34 | ₹247.06 | ₹209.81 |
| Profit Before Tax | ₹120.53 | ₹133.99 | ₹74.28 | ₹72.07 |
| Tax | ₹18.11 | ₹25.87 | ₹18.75 | ₹17.56 |
| Profit After Tax | ₹102.42 | ₹108.12 | ₹55.53 | ₹54.51 |
| EPS - Basic | ₹9.16 | ₹9.67 | ₹4.97 | ₹4.88 |
| EPS - Diluted | ₹9.15 | ₹9.66 | ₹4.97 | ₹4.87 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹120.53 | ₹133.99 | ₹74.28 | ₹72.07 |
| Income before WC changes | ₹76.83 | ₹110.40 | ₹79.35 | ₹73.75 |
| Change in Assets | ₹4.29 | -₹34.98 | -₹13.03 | -₹11.16 |
| Change in Liabilities | ₹3.91 | ₹3.42 | ₹0.43 | -₹4.04 |
| Change in WC | ₹8.19 | -₹31.57 | -₹12.60 | -₹15.21 |
| Cash flow from Operations | ₹63.48 | ₹51.63 | ₹50.30 | ₹37.10 |
| Cash flow from Investing | -₹1.74 | -₹2.70 | -₹42.35 | -₹14.24 |
| Cash flow from Financing | -₹57.63 | -₹56.88 | -₹11.99 | -₹10.87 |
| Total Cash Flow | ₹4.11 | -₹7.95 | -₹4.05 | ₹11.99 |
| Cash (Start of the year) | ₹1.50 | ₹9.45 | ₹13.50 | ₹1.51 |
| Cash (End of the year) | ₹5.60 | ₹1.50 | ₹9.45 | ₹13.50 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹456.43 | ₹384.59 | ₹386.26 | ₹352.94 |
| Current Assets | ₹232.20 | ₹248.34 | ₹189.54 | ₹176.69 |
| Total Assets | ₹688.63 | ₹632.93 | ₹575.80 | ₹529.62 |
| Current Liabilities | ₹44.70 | ₹40.01 | ₹36.90 | ₹36.31 |
| Net Current Asset | ₹187.50 | ₹208.33 | ₹152.64 | ₹140.38 |
| Non-Current Liabilities | ₹14.59 | ₹12.45 | ₹13.57 | ₹12.96 |
| Equity Capital | ₹629.34 | ₹580.47 | ₹525.33 | ₹480.35 |
| Total Equity & Liabilities | ₹688.63 | ₹632.93 | ₹575.80 | ₹529.62 |
About Advanced Enzyme Tech
Advanced Enzyme Technologies Limited is an India-based company engaged in the manufacturing of enzymes and probiotics. It is focused on the research and development, manufacturing, and marketing of approximately 400 products, developed from over 68 enzymes and probiotics. It operates in a business segment-manufacturing and sales of enzymes. It provides solutions to various industries, including human healthcare and nutrition, animal nutrition, baking, fruit and vegetable processing, brewing and malting, grain processing, protein modification, dairy processing, textile processing, and others. Its products and solutions for human nutrition include Serratiopeptidase, Fungal Lactase, Fungal Lipase, and Papain. Its probiotic offerings include both Human Nutrition - Enzyme Probiotics and Animal Nutrition - Enzyme Probiotics. In animal nutrition, its products are DigeGrain X, DigeGrain XL, and DigeGrain M. Its food processing solutions cover Dairy and Cheese Processing and Yeast Processing.
Advanced Enzyme Tech Financial Highlights
- Revenue: Advanced Enzyme Tech reported revenue of ₹780.59 crore in FY26 vs ₹669.95 crore in FY25. It showed an increase of 16.51% on a yearly basis.
- Operating Profit: Advanced Enzyme Tech reported an operating profit of ₹232.54 crore in FY26 vs ₹187.36 crore in FY25. It showed an increase of 24.11% on a year-on-year basis.
- Net Profit: Advanced Enzyme Tech reported a net profit of ₹173.61 crore in FY26 vs ₹133.97 crore in FY25. It showed an increase of 29.59% on a yearly basis.
Advanced Enzyme Tech Quarterly Result Highlights
- Advanced Enzyme Tech reported revenue of ₹210.60 crore in Mar 2026, compared with ₹180.42 crore in Dec 2025, representing an increase of 16.73% on a quarter-on-quarter (QoQ) basis.
- Advanced Enzyme Tech reported an operating profit of ₹59.80 crore in Mar 2026, compared with ₹58.29 crore in Dec 2025, representing an increase of 2.59% on a quarter-on-quarter (QoQ) basis.
- Advanced Enzyme Tech reported a profit of ₹45.25 crore in Mar 2026, compared with ₹43.18 crore in Dec 2025, reflecting an increase of 4.79% on a QoQ basis.
- The earnings per share (EPS) of Advanced Enzyme Tech stood at ₹11.72 during Mar 2026.
Similar Stocks
FAQs on Advanced Enzyme Tech Share Price
What is Advanced Enzyme Tech share price today?
Advanced Enzyme Tech share price is ₹317.60 as on 03 Jul, 2026, 15:54 IST.
How has the Advanced Enzyme Tech share price performed in the past?
In the last 1 year, Advanced Enzyme Tech delivered a return of -6.02%. The Advanced Enzyme Tech share price hit a high of ₹419.00 and low of ₹251.95.
How much is the Mutual Fund shareholding in Advanced Enzyme Tech shares?
The Mutual Fund Shareholding in Advanced Enzyme Tech was 1.93% at the end of Mar 2026.
What is the the 52-week high and low of Advanced Enzyme Tech shares ?
The 52-week high and low of Advanced Enzyme Tech share is ₹419.00 and ₹251.95 as of 03 Jul, 2026.
What is the market cap of Advanced Enzyme Tech?
The market capitalisation of Advanced Enzyme Tech is ₹3,511.57 Crores as on 03 Jul, 2026.
What are the stock symbols of Advanced Enzyme Tech?
The stock symbol of Advanced Enzyme Tech is ADVENZYMES on the NSE, 540025 on the BSE, and the ISIN is INE837H01020.
What was yesterday's closing price of Advanced Enzyme Tech shares ?
Advanced Enzyme Tech shares closed yesterday at ₹313.45 on NSE & ₹313.60 on BSE
How to buy Advanced Enzyme Tech shares?
To buy Advanced Enzyme Tech shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy Advanced Enzyme Tech shares on Holidays?
No, shares of Advanced Enzyme Tech or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Advanced Enzyme Tech shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Advanced Enzyme Tech?
The PE and PB ratio of Advanced Enzyme Tech is 20.23 and 2.15 respectively, as on 03 Jul, 2026, 15:54 IST.